Preclinical data support the involvement of the 5-HT4R in treatment mechanisms of anxiety and depression; for instance, administration of 5-HT4R agonists to rodents generates rapid anxiolytic-like and antidepressant-like behavior [15, 16], possibly via supporting hippocampal neurogenesis [17]. The gene discussed is HTR4; the disease is depressive symptom measurement.